Free Shipping Over $300Dispatched Within 48 hours From AUSSpend $450 — 20% OffThird-Party COA VerifiedFree Shipping Over $300Dispatched Within 48 hours From AUSSpend $450 — 20% OffThird-Party COA Verified
Silverback Peptides

Evidence-based summaries

ResearchHub

Compound data, published study summaries, and storage guides for laboratory researchers. All content framed for research contexts only.

⚠️

Research use only. Not medical advice. Review primary sources before citing.

◆ Featured Article

🧪
Weightloss · Triple Agonist · GLP-1 / GIP / Glucagon

Retatrutide (LY3437943): Mechanism, Clinical Studies & Research Data

Verified compound data and published clinical trial summaries for retatrutide (LY3437943), the triple-receptor agonist studied in the TRIUMPH and Phase 2 obesity trials. CAS, molecular weight, mechanism and references.
Silverback Research Team·9 min read

All Articles

⚗️Bestseller
Recovery
BPC-157: Body Protection Compound Research Overview
Verified compound data and published research summaries for BPC-157 (Body Protection Compound-157). Covers the confirmed sequence, VEGFR2 and FAK-paxillin mechanisms, regulatory status, and the absence of controlled human trials.
7 min read
💉Essential
Storage Guides
Peptide Storage & Reconstitution: The Complete Lab Guide
A practical guide to storing and reconstituting lyophilised research peptides — solvent selection, temperature ranges, reconstitution method, concentration math, and shelf-life best practices.
6 min read
🧫
Recovery
TB-500 (Thymosin Beta-4 Fragment): Mechanism & Research Data
Verified compound data for TB-500 (Ac-LKKTETQ), the actin-sequestering heptapeptide fragment of Thymosin Beta-4. Covers the critical CAS distinction from the full-length protein, mechanism, and the current state of human evidence.
7 min read
💊Comparison
Weightloss
Semaglutide vs Tirzepatide vs Retatrutide: A Research Comparison
Verified comparison of semaglutide (GLP-1), tirzepatide (GLP-1/GIP) and retatrutide (GLP-1/GIP/glucagon). Receptor targets, regulatory status, and the headline weight-loss figures from STEP-1, SURMOUNT-1 and the retatrutide trials.
9 min read
🔬
Sexual Health
PT-141 (Bremelanotide): Melanocortin Agonist Research Summary
Verified compound data for PT-141 (bremelanotide), the MC3R/MC4R melanocortin agonist. Covers the cyclic heptapeptide structure, central-nervous-system mechanism, RECONNECT Phase 3 trial data, and US vs Australian regulatory status.
8 min read
Cosmetic
GHK-Cu: Copper Tripeptide Complex Research Summary
Verified compound data for GHK-Cu (Copper Tripeptide-1), the glycyl-histidyl-lysine copper complex. Covers the square-planar copper coordination, collagen and matrix-remodelling research, and laboratory handling including pH stability.
7 min read